Radiotherapy plays an important part in the management of breast cancer. Especially after breast-conserving surgery, external whole breast irradiation, occasionally with an additional local boost, is an integral part of breast conservation. Besides external radiation techniques, brachytherapy (BT) has long been among the treatment options, especially with regard to local boost application. With the emerging implementation of accelerated partial breast irradiation (APBI), BT in general and interstitial multi-catheter BT in particular, are gaining an increasing role in the management of a selected group of early breast cancer patients. APBI is an approach to reduce the irradiated area to the former tumor bed rather than treating the whole breast tissue in patients with a low baseline local recurrence risk. After a variety of phase I-III clinical studies, it is clearly evident that APBI will play a role in the treatment of this selected patient group. In this review, we focus on the clinical development and different available techniques of breast BT and provide a preview of prospects for its use.

1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
[PubMed]
2.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after breast-conserving surgery on 10-yearrecurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011;378:1707-1716.
[PubMed]
3.
Haviland JS, Owen JR, Dewar JA, et al.; START Trialists' Group: The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:1086-1094.
[PubMed]
4.
Whelan TJ, Pignol JP, Levine MN, et al: Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-520.
[PubMed]
5.
Gerbaulet A, Pötter R, Mazeron J-J, Meertens Harm, van Limbergen E (eds): The GEC ESTRO Handbook of Brachytherapy. Leuven, Belgium, European Society for Therapeutic Radiology and Oncology, 2002.
6.
Njeh CF, Saunders MW, Langton CM: Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol 2010;5:90.
[PubMed]
7.
Offersen BV, Overgaard M, Kroman N, Overgaard J: Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 2009;90:1-13.
[PubMed]
8.
Kellermeier M, Fietkau R, Strnad V, Bert C: Assessment of the implant geometry in fractionated interstitial HDR breast brachytherapy using an electromagnetic tracking system. Brachytherapy 2018;17:94-102.
[PubMed]
9.
Berger D, Kauer-Dorner D, Seitz W, Pötter R, Kirisits C: Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy. Brachytherapy 2008;7:320-326.
[PubMed]
10.
Saw CB, Suntharalingam N, Wu A: Concept of dose nonuniformity in interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1993;26:519-527.
[PubMed]
11.
International Commission on Radiation Units and Measurements: Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. Report 38. Bethesda, 1985.
12.
White J, Winter K, Kuske RR, et al: Long-term cancer outcomes from study NRG Oncology/RTOG 9517: a phase 2 study of accelerated partial breast irradiation with multicatheter brachytherapy after lumpectomy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2016;95:1460-1465.
[PubMed]
13.
Skowronek J, Malicki J, Piotrowski T: Values of biologically equivalent doses in healthy tissues: comparison of PDR and HDR brachytherapy techniques. Brachytherapy 2010;9:165-170.
[PubMed]
14.
Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. Engl J Med 2002;347:1233-1241.
[PubMed]
15.
Bartelink H, Horiot JC, Poortmans PM, et al: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial Clin Oncol 2007;25:3259-3265.
[PubMed]
16.
Holland R, Veling SH, Mravunac M, Hendriks JH: Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979-990.
[PubMed]
17.
Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I: Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 1996;74:820-824.
[PubMed]
18.
Romestaing P, Lehingue Y, Carrie C, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15:963-968.
[PubMed]
19.
Polgár C, Fodor J, Orosz Z, et al: Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 2002;178:615-623.
[PubMed]
20.
Polgár C, Jánváry L, Major T, et al: The role of high-dose-rate brachytherapy boost in breast-conserving therapy: long-term results of the Hungarian National Institute of Oncology. Rep Pract Oncol Radiother 2010;15:1-7.
[PubMed]
21.
Quéro L, Guillerm S, Taright N, et al: 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment. Radiother Oncol 2017;122:11-16.
[PubMed]
22.
Skowronek J, Chicheł A: Brachytherapy in breast cancer: an effective alternative. Prz Menopauzalny 2014;13:48-55.
[PubMed]
23.
Bartelink H, Maingon P, Poortmans P, et al.; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups: Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 2015;16:47-56.
[PubMed]
24.
Poortmans P, Bartelink H, Horiot JC, et al.; EORTC Radiotherapy and Breast Cancer Groups: The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost' randomised trial. Radiother Oncol 2004;72:25-33.
[PubMed]
25.
Polgár C, Major T, Fodor J, et al: High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 2004;60:1173-1181.
[PubMed]
26.
Terheyden MM, Melchert C, Kovács G: External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison. J Contemp Brachytherapy 2016;8:294-300.
[PubMed]
27.
Kwa SL, Lebesque JV, Theuws JC, et al: Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998;42:1-9.
[PubMed]
28.
Bledsoe TJ, Nath SK, Decker RH: Radiation pneumonitis. Clin Chest Med 2017;38:201-208.
[PubMed]
29.
Grantzau T, Overgaard J: Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol 2015;114:56-65.
[PubMed]
30.
Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabár L, Nordgren H, Adami HO: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17:2326-2333.
[PubMed]
31.
Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986;57:1717-1724.
[PubMed]
32.
Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
[PubMed]
33.
Fentiman IS, Poole C, Tong D, et al: Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 1991;27:447-450.
[PubMed]
34.
Fentiman IS, Poole C, Tong D, et al: Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 1996;32A:608-611.
[PubMed]
35.
Perera F, Engel J, Holliday R, et al: Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 1997;65:263-267.
[PubMed]
36.
Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, Venkatesan V: Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 2003;57:1239-1246.
[PubMed]
37.
Arthur DW, Winter K, Kuske RR, et al: A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008;72:467-473.
[PubMed]
38.
Polgár C, Fodor J, Major T, Sulyok Z, Kásler M: Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 2013;108:197-202.
[PubMed]
39.
Strnad V, Hildebrandt G, Pötter R, et al: Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 2011;80:17-24.
[PubMed]
40.
Polgár C, Van Limbergen E, Pötter R, et al.; GEC-ESTRO Breast Cancer Working Group: Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010;94:264-273.
[PubMed]
41.
Aristei C, Maranzano E, Lancellotta V, et al: Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study. Radiother Oncol 2017;124:208-213.
[PubMed]
42.
Strnad V, Ott OJ, Hildebrandt G, et al.; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO): 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016;387:229-238.
[PubMed]
43.
Ott OJ, Strnad V, Hildebrandt G, et al.; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO): GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance. Radiother Oncol 2016;120:119-123.
[PubMed]
44.
Hannoun-Lévi JM, Cham Kee DL, Gal J, et al: Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: early results of the Single-Fraction Elderly Breast Irradiation (SiFEBI) phase I/II trial. Brachytherapy 2018;17:407-414.
[PubMed]
45.
Sumodhee S, Levy J, Chamorey E, et al: Accelerated partial breast irradiation for elderly women with early breast cancer: a compromise between whole breast irradiation and omission of radiotherapy. Brachytherapy 2017;16:929-934.
[PubMed]
46.
Genebes C, Chand ME, Gal J, et al: Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy. Radiat Oncol 2014;9:115.
[PubMed]
47.
Hannoun-Levi JM, Resch A, Gal J, et al.; GEC-ESTRO Breast Cancer Working Group: Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 2013;108:226-231.
[PubMed]
48.
Kauer-Dorner D, Pötter R, Resch A, et al: Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 2012;102:96-101.
[PubMed]
49.
Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D: Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Brachytherapy 2008;7:29-36.
[PubMed]
50.
Shah C, Badiyan S, Ben Wilkinson J, et al: Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite® breast brachytherapy registry trial. Ann Surg Oncol 2013;20:3279-3285.
[PubMed]
51.
Cuttino LW, Arthur DW, Vicini F, Todor D, Julian T, Mukhopadhyay N: Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial. Int J Radiat Oncol Biol Phys 2014;90:1025-1029.
[PubMed]
52.
Sedlmayer F, Reitsamer R, Wenz F, et al: Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiat Oncol 2017;12:23.
[PubMed]
You do not currently have access to this content.